James Engelhart, Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 2,500 shares at $27.67 ($69K) on 2018-05-07, disclosed to the SEC on 2018-05-09.
Open-market sale of $69k BHVN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BHVN | BUY | 2019-06-28 | $108K | — | Filing → |
| BHVN | SELL | 2018-05-30 | $175K | — | Filing → |
| BHVN | SELL | 2018-02-23 | $16K | — | Filing → |